NOVAVAX INC — Director's Dealing 2018

Nov 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2018-10-31

Reporting Person: King Rachel K. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-31	Stock Option (Right to buy)	$1.76	A	160000	Acquired	2028-10-31	Common Stock (160000)	Direct

Footnotes

F1: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the October 31, 2018 grant date subject to continued service on the Company's Board of Directors through the vesting date.